Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China flag China · Delayed Price · Currency is CNY
31.22
-1.70 (-5.16%)
Apr 9, 2026, 3:04 PM CST
Market Cap6.46B +144.2%
Revenue (ttm)1.45B -7.0%
Net Income108.09M +37.7%
EPS0.54 +35.9%
Shares Out196.11M
PE Ratio61.05
Forward PEn/a
Dividend0.20 (0.59%)
Ex-Dividend DateNov 24, 2025
Volume24,339,404
Average Volume12,874,915
Open33.01
Previous Close32.92
Day's Range30.51 - 33.13
52-Week Range11.44 - 68.80
Beta0.80
RSI47.91
Earnings DateApr 29, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 1,275
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002940
Full Company Profile

Financial Performance

In 2024, SHE:002940's revenue was 1.51 billion, a decrease of -6.63% compared to the previous year's 1.62 billion. Earnings were 80.33 million, a decrease of -41.94%.

Financial Statements